Large Atypical Lipomatous Tumours of the Limbs: A Report of Three Cases

  • Hemza Amrane Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid -, 53 Constantine Road, Fesdis 05078, Batna, Algeria.
  • Toufik Boussha Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
  • Ilies Hasrouri Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
  • Besma Mekideche Orthopaedic Surgery, Batna Specialist Emergency Hospital, Batna, Algeria
  • Moussa Amrane Laboratory LGC-ROI, Department of Civil Engineering, Faculty of Technology, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
  • Nazim Benmayouf Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
  • Chaouki Derdous Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
  • Nacer Khernane Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid, Batna, Algeria
Keywords: Liposarcoma, atypical, Well-differentiated liposarcoma, Surgical procedures, operative, Prognosis, Recurrence

Abstract


Atypical lipomatous tumours (ALT) are rare adipocytic neoplasms classified under well-differentiated liposarcomas. Although they have low metastatic potential, their progressive growth and anatomical location can lead to significant functional impairments. Complete surgical excision remains the primary treatment; however, challenges arise when these tumours are located near critical neurovascular structures. This study presents three clinical cases of large ALT in the limbs, analysing the diagnostic, surgical and prognostic aspects. This study reports on three patients (ages 64, 70, and 69) who presented with large, slowly growing lipomatous masses in the limbs, evolving over several years. The tumours, ranging from 25 to 60 cm in size, were assessed using imaging techniques, including MRI and CT scans. Surgical excision was performed in all cases, ensuring complete tumour resection while preserving adjacent neurovascular structures. Histopathological analysis confirmed the diagnosis of ALT. Postoperative functional recovery and recurrence were monitored over a follow-up period of 24 months. All patients experienced significant clinical improvement, with full restoration of joint mobility and resolution of sensory disturbances. No local tumour recurrence was observed. Postoperative imaging demonstrated effective tissue regeneration without excessive fibrosis or adhesions. The quality-of-life assessment using the Toronto Extremity Salvage Score (TESS) indicated a marked improvement in motor function and autonomy. ALT, despite being a low-grade tumour, requires a multidisciplinary approach for optimal management. Complete surgical excision ensures excellent long-term outcomes, but extended clinical and radiological surveillance remains crucial. Advancements in molecular pathology and imaging techniques may further refine treatment strategies and enhance patient prognosis.

References

Choi JH, Ro JY. The recent advances in molecular diagnosis of soft tissue tumors. Int J Mol Sci. 2023 Mar 21;24(6):5934. doi: 10.3390/ijms24065934.

Oshiro H, Mizuta K, Tsuha Y, Aoki Y, Katsuki R, Tome Y, et al. Differential Diagnosis of lipomatous tumors using 18f-fluorodeoxygulcose positron emission tomography/computed tomography: a retrospective observational study. Cancer Diagn Progn. 2024 Mar 3;4(2):141-6. doi: 10.21873/cdp.10300.

Oh YJ, Yi SY, Kim KH, Cho YJ, Beum SH, Lee YH, et al. Prognostic model to predict survival outcome for curatively resected liposarcoma: a multi-institutional experience. J Cancer. 2016 Jun 7;7(9):1174-80. doi: 10.7150/jca.15243.

Fuchs JW, Schulte BC, Fuchs JR, Agulnik M. Targeted therapies for the treatment of soft tissue sarcoma. Front Oncol. 2023 Mar 9;13:1122508. doi: 10.3389/fonc.2023.1122508.

Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2021 Apr;113(2):70-84. doi: 10.32074/1591-951X-213.

Gómez-Álvarez, J., et al. (2022). Dose-volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy. Radiotherapy and Oncology, 170, 159-164.

Gómez J, Tsagozis P. Multidisciplinary treatment of soft tissue sarcomas: An update. World J Clin Oncol. 2020 Apr 24;11(4):180-9. doi: 10.5306/wjco.v11.i4.180.

Spalato-Ceruso M, Ghazzi NE, Italiano A. New strategies in soft tissue sarcoma treatment. J Hematol Oncol. 2024;17:76. doi: 10.1186/s13045-024-01580-3.

Pavlidis ET, Pavlidis TE. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy. World J Clin Oncol. 2023 Feb 24;14(2):89-98. doi: 10.5306/wjco.v14.i2.89.

Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumors of soft tissue and bone. Geneva: World Health Organization Press; 2021.

Folpe AL. Selected topics in the pathology of epithelioid soft tissue tumors. Mod Pathol. 2014 Jan;27 Suppl 1:S64-79. doi: 10.1038/modpathol.2013.175..

Gonzalez MR, Mendez-Guerra C, Goh MH, Pretell-Mazzini J. Principles of Surgical Treatment of Soft Tissue Sarcomas. Cancers (Basel). 2025 Jan 25;17(3):401. doi: 10.3390/cancers17030401.

Published
2025/04/30
Section
Case report